Massachusetts Eye and Ear Infirmary
People
Professor
Professor
Professor
Primary investigator
Associate professor of ophthalmology
Head and neck oncologic surgeon
Professor
M. Charles Liberman
Professor
Associate professor
Rosario FernáNdez Godino
Lead investigator
Principal investigator
Professor
Professor of ophthalmology
Director of epidemiology for dept of oph
Sources: reporter.nih.gov, openalex.org
Trials
Topical Insulin Therapy for Persistent Corneal Epithelial Defects
Early phase 1, Not yet recruiting, 40 people, Nov 20, 2026
Tirzepatide for the REduction of AceTazolamide in Idiopathic Intracranial Hypertension
Collaborator, Phase 2, Not yet recruiting, 75 people, Nov 18, 2026
Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea With Complete Concentric Collapse
Collaborator, Not yet recruiting, 20 people, Oct 27, 2026
Recruiting, 45 people, Jul 6, 2026
Phase 1, Not yet recruiting, 8 people, Apr 13, 2025
Phase 1, Not yet recruiting, 50 people, May 22, 2024
OCT Vibrography for Biomechanical Properties of Tissues
Collaborator, Recruiting, 90 people, Mar 8, 2023
Oral N-acetylcysteine for Retinitis Pigmentosa
Collaborator, Phase 3, Active, not recruiting, 485 people, Sep 13, 2022
Doxycycline in Cutaneous Schwannoma (NF2)
Phase 1/2, Active, not recruiting, 19 people, Aug 30, 2022
Phase 4, Completed, 168 people, Apr 15, 2022
Early phase 1, Recruiting, 165 people, Feb 1, 2022
Phase 2, Recruiting, 21 people, Feb 3, 2021
Phase 1, Terminated, 1 person, Aug 5, 2020
Phase 2, Recruiting, 45 people, Jun 19, 2020
Feasibility Tests for Various Prism Configurations for Visual Field Loss
Completed, 10 people, Jun 11, 2020
Phase 2, Completed, 29 people, Mar 25, 2020
Phase 1/2, Recruiting, 6 people, Jan 13, 2020
Early phase 1, Status unknown, 33 people, Jan 31, 2019
Phase 1, Withdrawn, 0 people, Dec 28, 2017
Phase 3, Status unknown, 124 people, Sep 27, 2017
Sources: clinicaltrials.gov
Grants and prizes
R01, Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration, R01EY030088, $693K, 2020–2030, Sep 7, 2026
National Center for Chronic Disease Prev and Health Promo
U01, DP24-081 The Glaucoma and Retinopathy Screening Study, U01DP006822, $750K, 2024–2029, Aug 15, 2026
National Institute on Deafness and Other Communication Disorders
P50, Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences, P50DC015857, $2.7M, 2017–2027, Jul 31, 2026
R01, Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine Learning, R01EY036518, $698K, 2024–2029, Jul 27, 2026
R01, Contribution of vestibular dysfunction and its central multisensory integration to imbalance in aging, R01AG075532, $582K, 2024–2029, Jun 23, 2026
R01, Cell Biology of Astrocyte-Ganglion Cell Interactions in the Retina and Optic Nerve, R01EY019703, $425K, 2009–2029, Jun 1, 2026
R01, Blood-based early detection of viral precancers, R01CA311332, $642K, 2026–2031, May 22, 2026
National Institute on Deafness and Other Communication Disorders
R01, Measurements and Mechanisms of High Frequency Bone Conduction in Humans., R01DC023531, $655K, 2026–2031, May 11, 2026
National Institute on Deafness and Other Communication Disorders
R01, Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells, R01DC020322, $617K, 2022–2027, May 1, 2026
National Institute on Deafness and Other Communication Disorders
R01, Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments, R01DC000188, $672K, 1982–2028, Feb 10, 2026
R01, Novel Neuromodulation Treatment of Age Related Vestibular Loss to Improve Balance and Gait in Elderly Individuals, R01AG073161, $173K, 2021–2027, Aug 7, 2025
K00, Dual CRISPR/Cas9 exon deleting approach for the treatment of USH2A-associated disorders, K00EY037098, $88.6K, 2021–2028, Jun 25, 2024
National Institute on Deafness and Other Communication Disorders
K08, Mechanisms of Conductive Presbycusis in Humans, K08DC018575, $190K, 2020–2025, Mar 19, 2024
National Center for Advancing Translational Sciences
UH3, Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles, UH3TR002636, $1.6M, 2018–2024, Jul 25, 2022
Macular Degeneration Research: Other, Biomechanical properties of the Bruch's membrane and their relevance to the RPE pathology in AMD, M2021014N, $450K, 2022–2025, Mar 1, 2022
R13, 4th Harvard Biennial International Ocular Regeneration Symposium: From Bench to Bedside, R13EY031922, $24K, 2020–2023, Sep 3, 2020
R01, Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma, R01EY020928, $398K, 2011–2021, Aug 21, 2020
R21, Identifying Protective and Risk Factors for Non-infectious Uveitis, R21EY029851, $206K, 2019–2021, Feb 14, 2020
National Institute on Deafness and Other Communication Disorders
R01, Wnt Signaling in Hair Cell Generation from Supporting Cells, R01DC014089, $355K, 2015–2021, Nov 19, 2019
R13, The Third International Biennial Symposium on Ocular Regeneration: Tissue Engineering and the Eye, R13EY029551, $24K, 2018–2019, Aug 2, 2018
Sources: reporter.nih.gov, openalex.org
Funded papers
Sep 21, 2026
Nov 22, 2024
Sep 1, 2023
Jul 31, 2023
Imaging Cataract-Specific Peptides in Human Lenses
Dec 14, 2022
Apr 21, 2021
Dec 1, 2020
P30EY003790, Nov 7, 2019
The effects of age and cognitive load on peripheral-detection performance
Jan 2, 2019
The Complement System Is Critical in Maintaining Retinal Integrity during Aging
Feb 15, 2018
Sources: openalex.org
Papers
Pupil size linked to speech recognition lapses in older adults
The Journal of neuroscience : the official journal of the Society for Neuroscience, Nov 13, 2026
Updated genetic score improves glaucoma risk prediction
Ophthalmology, Nov 12, 2026
Chest X-ray model flags chronic obstructive pulmonary disease risk
The Lancet. Digital health, Nov 11, 2026
Healthy-diet blood patterns linked to lower odds of eye disease
Investigative ophthalmology & visual science, Nov 4, 2026
iScience, Oct 30, 2026
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Risk of Retinal Vascular Occlusions
Journal of vitreoretinal diseases, Oct 20, 2026
Genetic scores linked to skin cancer risk in hypothyroidism
medRxiv, Oct 19, 2026
Scientific reports, Oct 17, 2026
Frontiers in aging, Oct 12, 2026
Rare gene variant linked to less decline in brain glucose use
Research square, Oct 8, 2026
Engineered cardiac transcription factor restores vision and reduces frailty in aging mice
bioRxiv, Oct 2, 2026
Macrophage-derived VEGFA maintains eye outflow in mice
bioRxiv : the preprint server for biology, Oct 2, 2026
Long-term proton-pump inhibitor use linked to eye disease
BMJ open ophthalmology, Sep 23, 2026
Research Square, Sep 22, 2026
American journal of ophthalmology, Sep 17, 2026
Older-looking retinas linked to smoking and diabetes
GeroScience, Sep 17, 2026
Pre-Diagnostic Plasma Endogenous Steroids and the Risk of Exfoliation Glaucoma
Investigative ophthalmology & visual science, Sep 14, 2026
Ophthalmology. Retina, Sep 3, 2026
Ophthalmic surgery, lasers & imaging retina, Sep 2, 2026
Plasma Biomarker Profiles in a Colombian Cohort of Heterozygous APOE3-Christchurch Carriers
Research Square, Aug 19, 2026